205 related articles for article (PubMed ID: 17904788)
21. Repressor roles for TCF-4 and Sfrp1 in Wnt signaling in breast cancer.
Shulewitz M; Soloviev I; Wu T; Koeppen H; Polakis P; Sakanaka C
Oncogene; 2006 Jul; 25(31):4361-9. PubMed ID: 16532032
[TBL] [Abstract][Full Text] [Related]
22. HIC1 attenuates Wnt signaling by recruitment of TCF-4 and beta-catenin to the nuclear bodies.
Valenta T; Lukas J; Doubravska L; Fafilek B; Korinek V
EMBO J; 2006 Jun; 25(11):2326-37. PubMed ID: 16724116
[TBL] [Abstract][Full Text] [Related]
23. Novel approach to abuse the hyperactive K-Ras pathway for adenoviral gene therapy of colorectal cancer.
Naumov I; Kazanov D; Lisiansky V; Starr A; Aroch I; Shapira S; Kraus S; Arber N
Exp Cell Res; 2012 Jan; 318(2):160-8. PubMed ID: 22020090
[TBL] [Abstract][Full Text] [Related]
24. Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.
Chen G; A J; Wang M; Farley S; Lee LY; Lee LC; Sawicki MP
Mol Cancer Res; 2008 Dec; 6(12):1894-907. PubMed ID: 19074834
[TBL] [Abstract][Full Text] [Related]
25. An oncolytic adenovirus vector combining enhanced cell-to-cell spreading, mediated by the ADP cytolytic protein, with selective replication in cancer cells with deregulated wnt signaling.
Toth K; Djeha H; Ying B; Tollefson AE; Kuppuswamy M; Doronin K; Krajcsi P; Lipinski K; Wrighton CJ; Wold WS
Cancer Res; 2004 May; 64(10):3638-44. PubMed ID: 15150123
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of Wnt-1 in thyrocytes enhances cellular growth but suppresses transcription of the thyroperoxidase gene via different signaling mechanisms.
Kim WB; Lewis CJ; McCall KD; Malgor R; Kohn AD; Moon RT; Kohn LD
J Endocrinol; 2007 Apr; 193(1):93-106. PubMed ID: 17400807
[TBL] [Abstract][Full Text] [Related]
27. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival.
Alves-Guerra MC; Ronchini C; Capobianco AJ
Cancer Res; 2007 Sep; 67(18):8690-8. PubMed ID: 17875709
[TBL] [Abstract][Full Text] [Related]
28. Activation of the glutathione peroxidase 2 (GPx2) promoter by beta-catenin.
Kipp A; Banning A; Brigelius-Flohé R
Biol Chem; 2007 Oct; 388(10):1027-33. PubMed ID: 17937616
[TBL] [Abstract][Full Text] [Related]
29. Replicating adenoviruses that target tumors with constitutive activation of the wnt signaling pathway.
Brunori M; Malerba M; Kashiwazaki H; Iggo R
J Virol; 2001 Mar; 75(6):2857-65. PubMed ID: 11222711
[TBL] [Abstract][Full Text] [Related]
30. Nitro-aspirin inhibits MCF-7 breast cancer cell growth: effects on COX-2 expression and Wnt/beta-catenin/TCF-4 signaling.
Nath N; Vassell R; Chattopadhyay M; Kogan M; Kashfi K
Biochem Pharmacol; 2009 Nov; 78(10):1298-304. PubMed ID: 19576865
[TBL] [Abstract][Full Text] [Related]
31. [Stable suppression of beta-catenin expression in prostate cancer cell line by retrovirus mediated RNAi].
Hu Z; Cai F; Cheng LJ; Xia K; Xia JH; Zhang ZH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):253-7. PubMed ID: 16045007
[TBL] [Abstract][Full Text] [Related]
32. Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling.
Herzig M; Savarese F; Novatchkova M; Semb H; Christofori G
Oncogene; 2007 Apr; 26(16):2290-8. PubMed ID: 17043652
[TBL] [Abstract][Full Text] [Related]
33. Targeting the WNT/beta-catenin/TCF/LEF1 axis in solid and haematological cancers: Multiplicity of therapeutic options.
Gehrke I; Gandhirajan RK; Kreuzer KA
Eur J Cancer; 2009 Nov; 45(16):2759-67. PubMed ID: 19729298
[TBL] [Abstract][Full Text] [Related]
34. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
35. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
[TBL] [Abstract][Full Text] [Related]
36. [Identification of Wnt/beta-catenin signal pathway in human prostate cancer cell lines and its significance].
Jiang YG; Zhao JH; Luo Y; He DL; Wang XY; Cui XH
Zhonghua Nan Ke Xue; 2009 Apr; 15(4):310-3. PubMed ID: 19472902
[TBL] [Abstract][Full Text] [Related]
37. Mapping canonical Wnt signaling in the developing and adult retina.
Liu H; Thurig S; Mohamed O; Dufort D; Wallace VA
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5088-97. PubMed ID: 17065530
[TBL] [Abstract][Full Text] [Related]
38. Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.
Renard CA; Labalette C; Armengol C; Cougot D; Wei Y; Cairo S; Pineau P; Neuveut C; de Reyniès A; Dejean A; Perret C; Buendia MA
Cancer Res; 2007 Feb; 67(3):901-10. PubMed ID: 17283120
[TBL] [Abstract][Full Text] [Related]
39. The suppression of colon cancer cell growth in nude mice by targeting beta-catenin/TCF pathway.
Kwong KY; Zou Y; Day CP; Hung MC
Oncogene; 2002 Nov; 21(54):8340-6. PubMed ID: 12447697
[TBL] [Abstract][Full Text] [Related]
40. Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of beta-catenin.
Jin T; George Fantus I; Sun J
Cell Signal; 2008 Oct; 20(10):1697-704. PubMed ID: 18555664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]